Microvascular dysfunction is associated with a higher incidence of type 2 diabetes mellitus: A systematic review and meta-analysis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 12, 2012, Pages 3082-3094

  Muris, Dennis M J ^a   Houben, Alfons J H M ^a   Schram, Miranda T ^a   Stehouwer, Coen D A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

diabetes mellitus; meta analysis; microcirculation

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL REACTIVITY; COHORT ANALYSIS; DIET RESTRICTION; EMBASE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LONGITUDINAL STUDY; MEDLINE; META ANALYSIS; MICROVASCULAR DYSFUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINAL ARTERIOLE TO VENULE RATIO; SYSTEMATIC REVIEW; VASCULAR DISEASE; VISUAL SYSTEM PARAMETERS;

DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INCIDENCE; INSULIN RESISTANCE; MICROVESSELS; RISK FACTORS;

EID: 84870059676     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300291     Document Type: Article

References (55)

1. Jonk AM, Houben AJ, Schaper NC, de Leeuw PW, Serné EH, Smulders YM, Stehouwer CD. Angiotensin II enhances insulinstimulated wholebody glucose disposal but impairs insulininduced capillary recruitment in healthy volunteers. J Clin Endocrinol Metab. 2010;95:3901-3908.
2. Liu Z, Liu J, Jahn LA, Fowler DE, Barrett EJ. Infusing lipid raises plasma free fatty acids and induces insulin resistance in muscle microvasculature. J Clin Endocrinol Metab. 2009;94:3543-3549.
3. Jonk AM, Houben AJ, de Jongh RT, Serné EH, Schaper NC, Stehouwer CD. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesityassociated insulin resistance and hypertension. Physiology (Bethesda). 2007;22:252-260.
4. Rattigan S, Clark MG, Barrett EJ. Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes. 1997;46:1381-1388. (Pubitemid 27369072)
5. Czernichow S, Greenfield JR, Galan P, Bastard JP, Charnaux N, Samaras K, Safar ME, Blacher J, Hercberg S, Levy BI. Microvascular dysfunction in healthy insulinsensitive overweight individuals. J Hypertens. 2010;28:325-332.
6. Tack CJ, Ong MK, Lutterman JA, Smits P. Insulininduced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia. 1998;41:569-576. (Pubitemid 28206828)
7. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab. 2003;285:E123-E129. (Pubitemid 36736369)
8. Stehouwer CD. Is measurement of endothelial dysfunction clinically useful? Eur J Clin Invest. 1999;29:459-461. (Pubitemid 29271633)
9. de Jager J, Dekker JM, Kooy A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Endothelial dysfunction and lowgrade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Biol. 2006;26:1086-1093. (Pubitemid 43732116)
10. To SS, Newman PM, Hyland VJ, Robinson BG, Schrieber L. Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro. Arthritis Rheum. 1996;39:467-477. (Pubitemid 26085223)
11. Ikram MK, de Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM, de Jong PT. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci. 2004;45:2129-2134. (Pubitemid 38902580)
12. The Cochrane Collaboration. Review Manager (RevMan) [Computer program]. Version 5.0. Copenhagen, Denmark: The Nordic Cochrane Centre; 2008.
13. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intimamedia thickness: a systematic review and metaanalysis. Circulation. 2007;115:459-467. (Pubitemid 46184197)
14. Egger M, Smith GD, Altman DG. Statistical methods for examining heterogeneity and combining results from several studies in metaanalysis. In: Deeks, JJ, Altman DG, Bradburn MJ, eds. Systematic reviews in health care. Metaanalysis in context. 2001.
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in metaanalyses. BMJ. 2003;327:557-560.
16. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT; PREVEND Study Group. Urinary albumin excretion and its relation with Creactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care. 2005;28:2525-2530. (Pubitemid 41384305)
17. Duncan BB, Schmidt MI, Offenbacher S, Wu KK, Savage PJ, Heiss G. Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1999;22:767-772. (Pubitemid 29220777)
18. Friedman AN, Friedman A, Marrero D, Ma Y, Ackermann R, Narayan KM, BarrettConnor E, Watson K, Knowler WC, Horton ES; Diabetes Prevention Program Research Group. Value of urinary albumintocreatinine ratio as a predictor of type 2 diabetes in prediabetic individuals. Diabetes Care. 2008;31:2344-2348.
19. Halimi JM, Bonnet F, Lange C, Balkau B, Tichet J, Marre M; DESIR Study Group. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study. J Hypertens. 2008;26:2198-2206.
20. Ikram MK, Janssen JA, Roos AM, Rietveld I, Witteman JC, Breteler MM, Hofman A, van Duijn CM, de Jong PT. Retinal vessel diameters and risk of impaired fasting glucose or diabetes: the Rotterdam study. Diabetes. 2006;55:506-510. (Pubitemid 43343282)
21. Kifley A, Wang JJ, Cugati S, Wong TY, Mitchell P. Retinal vascular caliber and the longterm risk of diabetes and impaired fasting glucose: the Blue Mountains Eye Study. Microcirculation. 2008;15:373-377. (Pubitemid 351927726)
22. Meigs JB, O'donnell CJ, Tofler GH, Benjamin EJ, Fox CS, Lipinska I, Nathan DM, Sullivan LM, D'Agostino RB, Wilson PW. Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study. Diabetes. 2006;55:530-537. (Pubitemid 43343286)
23. Mykkänen L, Haffner SM, Kuusisto J, Pyorälä K, Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes. 1994;43:552-557. (Pubitemid 24096296)
24. Nguyen TT, Wang JJ, Islam FM, Mitchell P, Tapp RJ, Zimmet PZ, Simpson R, Shaw J, Wong TY. Retinal arteriolar narrowing predicts incidence of diabetes: the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Diabetes. 2008;57:536-539.
25. Perticone F, Maio R, Sciacqua A, Andreozzi F, Iemma G, Perticone M, Zoccali C, Sesti G. Endothelial dysfunction and Creactive protein are risk factors for diabetes in essential hypertension. Diabetes. 2008;57:167-171.
26. Sattar N, Murray HM, Welsh P, et al Prospective Study of Pravastatin in Elderly at Risk Trial Study Group. Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia. 2009;52:235-239.
27. Wang H, Shara NM, Calhoun D, Umans JG, Lee ET, Howard BV. Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study. Diabetes Metab Res Rev. 2010;26:378-385.
28. Wannamethee SG, Sattar N, Rumley A, Whincup PH, Lennon L, Lowe GD. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men. Diabetes Care. 2008;31:995-1000.
29. Wong TY, Klein R, Sharrett AR, Schmidt MI, Pankow JS, Couper DJ, Klein BE, Hubbard LD, Duncan BB; ARIC Investigators. Retinal arteriolar narrowing and risk of diabetes mellitus in middleaged persons. JAMA. 2002;287:2528-2533. (Pubitemid 34517198)
30. Wong TY, Shankar A, Klein R, Klein BE, Hubbard LD. Retinal arteriolar narrowing, hypertension, and subsequent risk of diabetes mellitus. Arch Intern Med. 2005;165:1060-1065. (Pubitemid 40638129)
31. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004;291:1978-1986. (Pubitemid 38544279)
32. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB, Hotamisligil GS, Ridker PM, Rodriguez BL, Margolis KL, Oberman A, Liu S. Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes. 2007;56:1898-1904. (Pubitemid 47025455)
33. Wang Z, Hoy WE. Albuminuria as a marker of the risk of developing type 2 diabetes in nondiabetic Aboriginal Australians. Int J Epidemiol. 2006;35:1331-1335. (Pubitemid 44605562)
34. Herder C, Baumert J, Zierer A, Roden M, Meisinger C, Karakas M, Chambless L, Rathmann W, Peters A, Koenig W, Thorand B. Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg casecohort study. PLoS ONE. 2011;6:e19852.
35. Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS. Circulating oxidised lowdensity lipoprotein and intercellular adhesion molecule1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Diabetologia. 2007;50:36-42. (Pubitemid 46035850)
36. Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care. 2003;26:1745-1751. (Pubitemid 36929114)
37. Stranges S, Rafalson LB, Dmochowski J, Rejman K, Tracy RP, Trevisan M, Donahue RP. Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study. Obesity (Silver Spring). 2008;16:1370-1376. (Pubitemid 351770535)
38. Thorand B, Baumert J, Chambless L, Meisinger C, Kolb H, Döring A, Löwel H, Koenig W; MONICA/KORA Study Group. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middleaged men and women from the general population. Arterioscler Thromb Vasc Biol. 2006;26:398-405. (Pubitemid 43732206)
39. Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH, Rattigan S. Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab. 2003;284:E241-E258. (Pubitemid 36120096)
40. Tal MG. Type 2 diabetes: Microvascular ischemia of pancreatic islets? Med Hypotheses. 2009;73:357-358.
41. De Jager J, Kooy A, Lehert P, Bets D, Wulffelé MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD. Effects of shortterm treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebocontrolled trial. J Intern Med. 2005;257:100-109. (Pubitemid 40129131)
42. Heyl W, Handt S, Reister F, Gehlen J, Mittermayer C, Rath W. The role of soluble adhesion molecules in evaluating endothelial cell activation in preeclampsia. Am J Obstet Gynecol. 1999;180(1 Pt 1):68-72. (Pubitemid 29088392)
43. Wolinsky H. A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis. Circ Res. 1980;47:301-311. (Pubitemid 10001078)
44. Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes. 1997;46 Suppl 2:S9-13.
45. Rubanyi GM. Endotheliumderived relaxing and contracting factors. J Cell Biochem. 1991;46:27-36.
46. Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, Evans G. Are retinal arteriolar abnormalities related to atherosclerosis?: The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol. 2000;20:1644-1650. (Pubitemid 30353900)
47. WilkinsonBerka JL. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase2 and nitric oxide. Curr Pharm Des. 2004;10:3331-3348.
48. Liew G, Wang JJ, Mitchell P, Wong TY. Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging. 2008;1:156-161.
49. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol. 2006;17:2106-2111. (Pubitemid 44141899)
50. Houlihan CA, Tsalamandris C, Akdeniz A, Jerums G. Albumin to creatinine ratio: a screening test with limitations. Am J Kidney Dis. 2002;39:1183-1189. (Pubitemid 34591933)
51. Price DT, Loscalzo J. Cellular adhesion molecules and atherogenesis. Am J Med. 1999;107:85-97. (Pubitemid 29328286)
52. Vischer UM, Emeis JJ, Bilo HJ, Stehouwer CD, Thomsen C, Rasmussen O, Hermansen K, Wollheim CB, Ingerslev J. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Thromb Haemost. 1998;80:1002-1007. (Pubitemid 28556706)
53. Schriger DL, Altman DG, Vetter JA, Heafner T, Moher D. Forest plots in reports of systematic reviews: a crosssectional study reviewing current practice. Int J Epidemiol. 2010;39:421-429.
54. Knotzer H, Hasibeder WR. Microcirculatory function monitoring at the bedside-a view from the intensive care. Physiol Meas. 2007;28:R65-R86. (Pubitemid 47304374)
55. Greenstein AS, Paranthaman R, Burns A, Jackson A, Malik RA, Baldwin RC, Heagerty AM. Cerebrovascular damage in latelife depression is associated with structural and functional abnormalities of subcutaneous small arteries. Hypertension. 2010;56:734-740.